• Anupriya
• Sazal Patyar

Osteoporosis is characterized by low bone mass and micro architecture deterioration of bone tissue and severe osteoporosis characterized by a disease of high mortality and morbidity. Risk increases exponentially with age and decrease in bone mass density. For management a deep understanding of biomechanics of osteoporotic bone and medical optimization is required. Worldwide belief is in average 5 women 3 women are at risk of getting osteoporotic fracture as well as 1 in 5 men. India with the population of 1.2 billion, 10% population is affected with osteoporosis. It is categorized into primary and secondary osteoporosis. There are various risk factors like age, hormonal disturbance, secondary hyperparathyroidism, hereditary and poor lifestyle. Repeatedly some drugs intake increases the risk of osteoporosis like glucocorticoids, proton pump inhibitors. Risk if fracture is higher in patients with higher incidents of falls as in hemiplegia, lower limb dysfunction. Methods to determine bone density are single and dual X-ray absorptiometry, computed tomography. Pharmacological therapy including vitamin D and calcium supplements, hormonal replacement therapies, serum estrogen receptor modulators and bisphosphonates. This paper highlight sorts of osteoporosis, its risk factor, management, pathophysiology of bone loss and about management of fractures.

Osteoporosis, osteonecrosis, bones, bone loss

"Clinical Management of Osteoporosis: An Overview", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.7, Issue 12, page no.1501-1511, December-2020, Available :http://www.jetir.org/papers/JETIR2012196.pdf

"Clinical Management of Osteoporosis: An Overview", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.7, Issue 12, page no. pp1501-1511, December-2020, Available at : http://www.jetir.org/papers/JETIR2012196.pdf